RNS Number : 2524C
Convatec Group PLC
06 October 2025
6 October 2025
Convatec Group Plc
("Convatec" or "the Company")
Director/ PDMR Shareholding
Non-Executive Director's Share Transfer
The Company has been notified of the following transactions in relation to Sharon O'Keefe, Non-Executive Director of the Company, in respect of ordinary shares of 10 pence each in the Company ("Shares").
The Company was notified on 3 October 2025 that Ms. O'Keefe had transferred 3,200 ordinary shares of 10 pence each in the Company as a charitable donation by way of a gift for nil consideration to The Chicago Community Trust, a community foundation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Sharon O'Keefe
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Convatec Group Plc
b)
LEI
213800LS272L4FIDOH92
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary share of 10p each in Convatec Group Plc
Identification code
GB00BD3VFW73
b)
Nature of the transaction
Transfer to The Chicago Community Trust
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0
3,200
d)
Aggregated information
- Aggregated volume
N/A - single transaction
- Price
£0
e)
Date of the transaction
3 October 2025
f)
Place of the transaction
Outside a trading venue
Enquiries
James Kerton Company Secretary
Tel: +44 (7827) 036059
Email: cosec@convatec.com
Convatec Group Plc's LEI code is 213800LS272L4FIDOH92
Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation
About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide our products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Convatec's revenues in 2024 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFVSIELRIIE
